ArticleBMC medical informatics and decision making2026
Effectiveness of artificial intelligence mobile app-guided prevention and treatment protocols on cancer patients and their impact on healthcare workers' competence.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArtificial intelligence-based mobile health applications are increasingly used in oncology care, mainly to support symptom monitoring and clinical workflows. However, there is limited evidence on applications that simultaneously support cancer patients through structured prevention and treatment guidance while enhancing healthcare workers’ competencies. This study aimed to assess the outcomes of an AI-based mobile application as a supportive tool for cancer patients and examine its impact on healthcare workers’ competence in routine oncology care.
methodsA quasi-experimental pre-post design was conducted with 60 cancer patients and 60 healthcare workers. The AI-based mobile application provided content on education, symptom management, and protocol-based support. Data was collected through structured online questionnaires before and after a 12-week intervention using five tools to assess usability, perceived benefits, efficiency of healthcare workers, health awareness, and selected chemotherapy-related symptoms. The same instruments were used for pre- and post-measurements without a control group.
resultsPost-intervention findings indicated improved patient-reported usability of the mobile application, with most participants reporting clarity and perceived usefulness, although some reported occasional confusion or irrelevant responses. Healthcare workers demonstrated statistically significant improvements in perceived efficiency and benefits related to application use (p < 0.01). An increase in reported health awareness among nurses was observed. Patients also reported reductions in the severity of chemotherapy-related symptoms.
conclusionThe findings suggest that the AI-based mobile application may serve as a supportive digital tool in oncology settings by assisting patients in following prevention and treatment guidance and supporting healthcare workers’ perceived efficiency and awareness. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.